Abstract:: The impact of genetic variants on gene expression has been intensely studied at the transcription level, yielding invaluable insights into the association between genes and the risk of complex disorders, such as schizophrenia (SCZ). However, the downstream impact of these variants and the molecular mechanisms connecting transcription variation to disease risk are not well understood. : We quantitated ribosome occupancy in prefrontal cortex samples of the BrainGVEX cohort. Together with transcriptomics and proteomics data from the same cohort, we performed cis-Quantitative Trait Locus (QTL) mapping and identified 3,253 expression QTLs (eQTLs), 1,344 ribosome occupancy QTLs (rQTLs), and 657 protein QTLs (pQTLs) out of 7,458 genes from 185 samples. Of the eQTLs identified, only 34% have their effects propagated to the protein level. Further analysis on the effect size of prefrontal cortex eQTLs identified from an independent dataset clearly replicated the post-transcriptional attenuation of eQTL effects. We identified omics-specific QTLs and investigated their potential in driving disease risks. Using a variant based approach, we found expression-specific QTLs (esQTLs) for 1,553 genes, ribosome-occupancy-specific QTLs (rsQTLs) for 155 genes, and protein-specific QTLs (psQTLs) for 161 genes. Among these omics-specific QTL, 38 showed strong colocalization with brain associated disorder GWAS signals, 29 of them are esQTLs. Because a gene could contain multiple QTL signals, each could either be shared across omics or omics-specific, we aggregated QTL signals from each omics for each gene and found 11 brain associated disorder risk genes that are driven predominantly by omics-specific QTL, all of them are driven by variants impacting transcriptional regulation. This gene-based approach also enabled us to categorize risk genes containing both omics-specific and shared QTL signals. The limited number of GWAS colocalization discoveries from gene-based omics-specific mapping, however, prompted us to take a complementary approach to investigate the functional relevance of genes driven predominantly by attenuated eQTL signals. Using S-PrediXcan we identified 74 SCZ risk genes across the three omics, 30% of which were novel, and 67% of these risk genes were confirmed to be causal in a MR-Egger test using data from the corresponding omics. Notably, 52 out of the 74 risk genes were identified using eQTL data and 68% of these SCZ-risk-gene-driving eQTLs show little to no evidence of driving corresponding variations at the protein level. : The effect of eQTLs on gene expression in the prefrontal cortex is commonly attenuated post-transcriptionally. Many of the attenuated eQTLs still correlate with GWAS signals of brain associated complex disorders, indicating the possibility that these eQTL variants drive disease risk through mechanisms other than regulating protein expression level. Further investigation is needed to elucidate the mechanistic link between attenuated eQTLs and brain associated complex disorders.

The transcription factor POU3F2 regulates a gene coexpression network in brain tissue from patients with psychiatric disorders.

Transcription factor POU3F2 regulates TRIM8 expression contributing to cellular functions implicated in schizophrenia

CASCADE TF-MIRNA-MRNA REGULATIONS IDENTIFIED BY CO-EXPRESSION NETWORK MODULES IN BRAINS OF PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER

Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia.

Genetic regulation of human brain proteome reveals proteins implicated in psychiatric disorders

Two Gene Co-expression Modules Differentiate Psychotics and Controls

Human forebrain organoids-based multi-omics analyses reveal PCCB's regulation on GABAergic system contributing to schizophrenia.

A Combined Analysis of Genome-Wide Expression Profiling of Bipolar Disorder in Human Prefrontal Cortex.

Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia.

Human forebrain organoid-based multi-omics analyses of PCCB as a schizophrenia associated gene linked to GABAergic pathways

Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays

Codes between Poles: Linking Transcriptomic Insights into the Neurobiology of Bipolar Disorder

Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia

Using three-dimensional regulatory chromatin interactions from adult and fetal cortex to interpret genetic results for psychiatric disorders and cognitive traits

Integrated Transcriptome Analysis Reveals Novel Molecular Signatures for Schizophrenia Characterization.

Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis

Network Modules Linking Expression and Methylation in Prefrontal Cortex of Schizophrenia

FoxP2 is Significantly Associated with Schizophrenia and Major Depression in the Chinese Han Population.

The impact of common variants on gene expression in the human brain: from RNA to protein to schizophrenia risk

A Novel Microrna and Transcription Factor Mediated Regulatory Network in Schizophrenia

Brain transcriptional regulatory architecture and schizophrenia etiology converge between East Asian and European ancestral populations